Bridgeway Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,000
| Closed | -$22.1K | – | 1274 |
|
|
2025
Q1 | $22.1K | Sell |
5,000
-260
| -5% | -$1.15K | ﹤0.01% | 1154 |
|
|
2024
Q4 | $36.8K | Sell |
5,260
-460
| -8% | -$3.22K | ﹤0.01% | 1166 |
|
|
2024
Q3 | $82.9K | Sell |
5,720
-2,500
| -30% | -$36.3K | ﹤0.01% | 1176 |
|
|
2024
Q2 | $599K | Hold |
8,220
| – | – | 0.01% | 822 |
|
|
2024
Q1 | $487K | Sell |
8,220
-2,455
| -23% | -$145K | 0.01% | 940 |
|
|
2023
Q4 | $781K | Buy |
10,675
+3,220
| +43% | +$236K | 0.02% | 823 |
|
|
2023
Q3 | $290K | Hold |
7,455
| – | – | 0.01% | 1017 |
|
|
2023
Q2 | $430K | Hold |
7,455
| – | – | 0.01% | 947 |
|
|
2023
Q1 | $485K | Hold |
7,455
| – | – | 0.01% | 895 |
|
|
2022
Q4 | $205K | Buy |
7,455
+5,000
| +204% | +$138K | 0.01% | 1082 |
|
|
2022
Q3 | $72K | Hold |
2,455
| – | – | ﹤0.01% | 1322 |
|
|
2022
Q2 | $47K | Hold |
2,455
| – | – | ﹤0.01% | 1285 |
|
|
2022
Q1 | $199K | Buy |
+2,455
| New | +$199K | ﹤0.01% | 1171 |
|